By: Mindy Valcarcel, Gabrielle M. Grasso
Oral JAK inhibitors are now considered the first-line treatment for adults with severe alopecia areata, with a preference for FDA-approved therapies, according to a Delphi consensus statement published in JAMA Dermatology